The Steve Jobs of Biotech | Brian Goodman, MPM Capital episode artwork

EPISODE · Jul 24, 2023 · 50 MIN

The Steve Jobs of Biotech | Brian Goodman, MPM Capital

from Nucleate Podcast · host Brian Goodman, Sam Kessel

What sparked Dr. Goodman’s interest in biotech (0:00)Deciding to pivot from academia to venture capital (3:45)Failing fast and applying that mindset to science (9:44)Transitioning from academia to a start up (14:44)Advice for aspiring technical founders (20:03)Becoming an investor at MPM Capital (30:24)MPM’s investment thesis in oncology. (40:14)

Episode metadata supplied by the publisher feed · Published Jul 24, 2023

Embed this episode

Summary In this episode we speak with Brian Goodman, PhD, Partner at MPM Capital who was previously an associate at flagship pioneering, co-founder of Avila biosciences, Aktis oncology, Renegade therapeutics, and Orna therapeutics. Brian talks about his scientific inspirations and the pivot from academic research to venture creation as well as the excitement and challenges that come with starting a biotech company. At MPM, Brian invests in and supports founders that are developing novel approaches to drug discovery and development.

Distinct summary based on available episode metadata or transcript content.

Ready to play

The Steve Jobs of Biotech | Brian Goodman, MPM Capital

0:00 50:53

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Nucleate Podcast?

This episode is 50 minutes long.

When was this Nucleate Podcast episode published?

This episode was published on July 24, 2023.

Can I download this Nucleate Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!